These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8709180

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis and in vitro/in vivo evaluation of novel mono- and trivalent technetium-99m labeled ghrelin peptide complexes as potential diagnostic radiopharmaceuticals.
    Koźmiński P, Gniazdowska E.
    Nucl Med Biol; 2015 Jan; 42(1):28-37. PubMed ID: 25218025
    [Abstract] [Full Text] [Related]

  • 3. Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals.
    Tisato F, Bolzati C, Porchia M, Refosco F.
    Mass Spectrom Rev; 2004 Jan; 23(5):309-32. PubMed ID: 15264232
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Water-stable fac-{TcO₃}⁺ complexes - a new field of technetium chemistry.
    Braband H.
    Chimia (Aarau); 2011 Jan; 65(10):776-81. PubMed ID: 22054130
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Technetium-99m radiochemistry for pharmaceutical applications.
    Papagiannopoulou D.
    J Labelled Comp Radiopharm; 2017 Sep; 60(11):502-520. PubMed ID: 28618064
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
    Yu F, Lü ML, Zhang XP, Fu D, Hou M, Cai HD, Li D, Wang J, Yuan XY, Lü ZW, Dong F.
    Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of routine radiochemical quality assurance testing of technetium Tc 99m radiopharmaceuticals.
    Ponto JA, Ponto LL.
    Am J Hosp Pharm; 1986 May; 43(5):1218-22. PubMed ID: 3087163
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals.
    Bartholomä M, Valliant J, Maresca KP, Babich J, Zubieta J.
    Chem Commun (Camb); 2009 Feb 07; (5):493-512. PubMed ID: 19283279
    [Abstract] [Full Text] [Related]

  • 18. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.
    Buja LM, Tofe AJ, Kulkarni PV, Mukherjee A, Parkey RW, Francis MD, Bonte FJ, Willerson JT.
    J Clin Invest; 1977 Sep 07; 60(3):724-40. PubMed ID: 893676
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Technetium-99m based small molecule radiopharmaceuticals and radiotracers targeting inflammation and infection.
    Kniess T, Laube M, Wüst F, Pietzsch J.
    Dalton Trans; 2017 Oct 31; 46(42):14435-14451. PubMed ID: 28829079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.